Centessa Pharmaceuticals's total assets for Q2 2024 were $398.85M, an increase of 21.54% from the previous quarter. CNTA total liabilities were $111.88M for the fiscal quarter, a -1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.